Many women diagnosed with ovarian cancer say that they had never heard of the disease or the symptoms associated with it
Ovarian cancer is the most deadly of the female cancers. This is partly due to the delays in diagnosis and because symptoms are often confused with those of other, less severe, illnesses. Therefore, most women are diagnosed once the cancer has already spread, making it more difficult to treat.
There is currently no test available for the screening of ovarian cancer. Even though every woman is at risk, ovarian cancer is overlooked and underfunded.
Symptoms linked to ovarian and endometrial cancer are vague including bloating, feeling full after a few bites, pain in the lower abdomen, and increased urinary frequency; more severe symptoms include post-menopausal bleeding and the presence of an abdominal mass.
The DOvEEgene test aims to detect ovarian and endometrial cancers before it’s too late.
Here are the eligibility requirements to participate in the clinical trial:
  • Be a woman between 45 and 70 years old
  • Never have had surgery to remove the uterus (hysterectomy)
Help us spread the message and make as many women aware, information has the power to save lives!

GENERAL ENQUIRIES

Maps image of the DOvEEgene location on McGill University Health Center

MEDIA ENQUIRIES

OFFICE HOURS

MON-FRI 8:30 am – 4:30 pm
Saturday Closed
Sunday Closed

Participate in the DOvEEgene Research Study!

We are currently located at 2111 Northcliffe Avenue, Montreal, QC and are taking appointments without referrals.  Click the Participate in Our Study button and book your appointment!